Drug interactions
Armodafinil + Rimegepant
Severity: Moderate
Armodafinil and Rimegepant: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Armodafinil may reduce rimegepant exposure, possibly diminishing migraine efficacy. Rimegepant labeling advises avoiding strong or moderate CYP3A inducers.
What this interaction means in plain words
Armodafinil and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Armodafinil belongs to Central Nervous System; Rimegepant belongs to Central Nervous System.
Why it happens
Armodafinil induces CYP3A4, increasing rimegepant metabolism.
What to do
Avoid the combination if possible and monitor migraine control. Consider an alternative acute therapy if response drops.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Rimegepant, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Armodafinil
Other interactions of Rimegepant
Frequently asked questions
Can I take Armodafinil with Rimegepant?
MediHelp rates the interaction as moderate. Armodafinil and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Armodafinil may reduce rimegepant exposure, possibly diminishing migraine efficacy. Rimegepant labeling advises avoiding strong or moderate CYP3A inducers.
How serious is the interaction between Armodafinil and Rimegepant?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible and monitor migraine control. Consider an alternative acute therapy if response drops.
What other medicines interact with Armodafinil?
MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
